That's good.
For SurgCentre.
They aren't Gregory's centres anymore either. GG is using the funds from the sale to buy Mesoblast (well, that's very likely - I'm betting he doesn't have a money tree).
After the risk off position is gained (with FDA approval for GVHD), wouldn't Mesoblast be best to get the best deal with a partner for CLBP and CHF? Because SI said that Mesoblast can't commercialise either without one. SurgCentre is not likely to manufacture the cells or pay for the manufacturing of the cells - they don't have the expertise or resources.
Big Pharma needed. SurgCentre is a potential venue after partnership. And by then, who cares where!
Your post is very pro-SurgCentre....and doesn't really make a lot of sense when you play it all out.
It's another 'HC fact', written in sand.
once approved, page-36
-
- There are more pages in this discussion • 79 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.18 |
Change
0.015(1.29%) |
Mkt cap ! $1.347B | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.20 | $1.15 | $4.551M | 3.886M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 98246 | $1.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.18 | 19079 | 2 |
View Market Depth
| Last trade - 16.10pm 16/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |